Comparative Evaluation of Effect of Nano-hydroxyapatite and 8% Arginine Containing Toothpastes in Managing Dentin Hypersensitivity: Double Blind Randomized Clinical Trial
Published In: Acta Medica (Hradec Králové)
Publication Year: 2017 (online 2018)
Study Design
This double-blind, randomized clinical trial compared the effectiveness of two active toothpastes — one containing nano-hydroxyapatite (nHA) and another with 8% arginine — in relieving dentin hypersensitivity (DH).
Sensitivity relief was assessed objectively using a digital pulp tester that measured the electrical current (amperage) needed to elicit a standardized “pre-pain” response (VAS = 2). Measurements were taken at 5 minutes, 1 week, and 4 weeks after starting treatment.
Funding Sources
The article did not report any funding sources or conflicts of interest.
PICO Framework - what was studied and how?
Population:
Adults with clinically confirmed dentin hypersensitivity who scored above 2 on a visual analog scale (VAS) after both air-blast and tactile tests. One sensitive tooth per participant was included.
Intervention:
Topical application and daily use of a toothpaste containing nano-hydroxyapatite (nHA).
Comparison:
Toothpaste containing 8% arginine, used following the same instructions and schedule.
Outcomes:
Reduction in hypersensitivity measured as the increase in electrical current (amperage) required to elicit a VAS = 2 response. A higher amperage indicates less sensitivity.
In Paragraph Form:
This randomized clinical trial evaluated adults experiencing dentin hypersensitivity to determine whether toothpaste with nano-hydroxyapatite or 8% arginine provided greater relief. Using a digital pulp tester, researchers measured the current needed to cause mild discomfort at baseline and again at 5 minutes, 1 week, and 4 weeks. The study aimed to identify which formulation most effectively reduced hypersensitivity over time.
Inclusion and Exclusion Criteria
Inclusion Criteria:
-
Adults with dentin hypersensitivity confirmed by both air-blast and tactile tests.
-
VAS score greater than 2.
-
One sensitive tooth per participant selected for testing.
-
Participants provided informed consent.
Exclusion Criteria:
-
Individuals not meeting inclusion criteria (29 excluded).
-
Participants who declined to participate (6 excluded).
-
The article did not list additional medical or dental exclusion details.
Demographics and Study Design
-
Total Participants: 60 (30 per group).
-
Randomization: 1:1 block randomization.
-
Blinding: Both investigators and participants were blinded to product identity.
-
Dropouts: None reported.
Baseline Characteristics:
| Variable | Arginine Group | nHA Group | p-value |
|---|---|---|---|
| Mean Age | 42.17 ± 7.34 | 42.33 ± 7.58 | 0.931 |
| Baseline Amperage | 6.27 ± 1.53 | 6.23 ± 1.25 | 0.927 |
| Sex (M/F) | 12/18 | 13/17 | 0.793 |
Home-use Instructions:
Participants applied approximately 1 cm of toothpaste directly to the sensitive area for 1 minute, followed by 2 minutes of brushing, twice daily for 4 weeks. No other oral hygiene products were permitted during the study period.
Primary Outcome Variables and Results
Outcome:
Change in electrical current (amperage) needed to elicit a “pre-pain” VAS = 2 response. A higher amperage indicates lower sensitivity.
Results:
Both toothpastes provided significant and immediate desensitizing effects at 5 minutes, with continued improvement at 1 and 4 weeks (p < 0.001 for all time points within groups).
Between-group differences:
No statistically significant difference was observed between nano-hydroxyapatite and arginine toothpastes at any time point.
| Time Point | 8% Arginine (mean ± SD) | nHA (mean ± SD) | p-value |
|---|---|---|---|
| 5 minutes | 1.97 ± 0.62 | 2.03 ± 0.41 | 0.624 |
| 1 week | 3.60 ± 0.93 | 3.70 ± 0.79 | 0.656 |
| 4 weeks | 5.00 ± 1.02 | 5.30 ± 1.02 | 0.259 |
Descriptive Mean Amperage Values:
-
Arginine group: 6.27 → 8.23 → 9.87 → 11.27
-
nHA group: 6.23 → 8.27 → 9.93 → 11.53
Key Statistical Findings:
-
Both groups improved significantly over time (p < 0.001).
-
No significant inter-group difference at any evaluation point (p > 0.05).
Conclusions
Both nano-hydroxyapatite and 8% arginine toothpastes provided immediate and sustained relief from dentin hypersensitivity after 5 minutes, 1 week, and 4 weeks of use.
There was no statistically significant difference in effectiveness between the two, suggesting that both active ingredients can offer comparable desensitizing benefits for patients experiencing dentin hypersensitivity.
Discussion: Strengths and Limitations
Strengths:
-
Randomized, double-blind design minimized bias.
-
Use of an objective measurement (digital pulp tester) ensured reproducibility.
-
Immediate and follow-up data points provided insight into both short-term and long-term relief.
Limitations:
-
Lack of a placebo or control group limited comparison against baseline improvement due to brushing alone.
-
Electrical measurement precision could vary with probe positioning; future studies should employ positioning jigs.
-
Study assessed only one sensitive tooth per participant, limiting generalization to multiple sites.
Clinical Significance:
Both formulations demonstrated reliable desensitizing effects, providing dental professionals and patients with viable non-fluoride options for managing dentin hypersensitivity.
Citation
Anand S, Rejula F, Sam JVG, Christaline R, Nair MG, Dinakaran S. Comparative Evaluation of Effect of Nano-hydroxyapatite and 8% Arginine Containing Toothpastes in Managing Dentin Hypersensitivity: Double Blind Randomized Clinical Trial. Acta Medica (Hradec Králové). 2017;60(3):114–119.
PubMed: https://pubmed.ncbi.nlm.nih.gov
Simple Chart: Dentin Hypersensitivity Reduction (Higher = Less Sensitivity)
| Time Point | 8% Arginine (mean ± SD) | nHA (mean ± SD) | p-value (vs nHA) |
|---|---|---|---|
| 5 minutes | 1.97 ± 0.62 | 2.03 ± 0.41 | 0.624 |
| 1 week | 3.60 ± 0.93 | 3.70 ± 0.79 | 0.656 |
| 4 weeks | 5.00 ± 1.02 | 5.30 ± 1.02 | 0.259 |
